Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Change in Receivables (2022 - 2025)

Lucid Diagnostics' Change in Receivables history spans 4 years, with the latest figure at $96000.0 for Q4 2025.

  • For Q4 2025, Change in Receivables rose 1271.43% year-over-year to $96000.0; the TTM value through Dec 2025 reached $601000.0, changed N/A, while the annual FY2025 figure was $601000.0, N/A changed from the prior year.
  • Change in Receivables reached $96000.0 in Q4 2025 per LUCD's latest filing, down from $177000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $312000.0 in Q2 2025 to a low of -$122000.0 in Q3 2024.
  • Average Change in Receivables over 4 years is $27875.0, with a median of $9000.0 recorded in 2023.
  • The largest YoY upside for Change in Receivables was 1287.5% in 2024 against a maximum downside of 771.43% in 2024.
  • A 4-year view of Change in Receivables shows it stood at -$14000.0 in 2022, then skyrocketed by 271.43% to $24000.0 in 2023, then plummeted by 70.83% to $7000.0 in 2024, then skyrocketed by 1271.43% to $96000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Change in Receivables are $96000.0 (Q4 2025), $177000.0 (Q3 2025), and $312000.0 (Q2 2025).